These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4030534)

  • 21. [Tobramycin-gentamicin: the To-Ge pretext of aminoside antibiotics].
    Morel C; Freymuth F
    Nouv Presse Med; 1973 Jan; 2(4):246. PubMed ID: 4568329
    [No Abstract]   [Full Text] [Related]  

  • 22. Intracellular activity of fosfomycin against two distinct enteropathogenic bacteria, Salmonella enterica and Listeria monocytogenes, alive inside host cells.
    Okada N; Nishio M; Danbara H
    Chemotherapy; 2003 May; 49(1-2):49-55. PubMed ID: 12714811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transferable gentamicin resistance in Enterobacter cloacae.
    Poston SM; Aubrey C; Cameron JM
    J Antimicrob Chemother; 1976 Jun; 2(2):189-94. PubMed ID: 783111
    [No Abstract]   [Full Text] [Related]  

  • 25. Bactericidal Effect of Pterostilbene Alone and in Combination with Gentamicin against Human Pathogenic Bacteria.
    Lee WX; Basri DF; Ghazali AR
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28304328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to nemonoxacin, tigecycline, fosfomycin and other antimicrobial agents.
    Hsu MS; Liao CH; Liu CY; Yang CJ; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2011 Mar; 37(3):276-8. PubMed ID: 21269811
    [No Abstract]   [Full Text] [Related]  

  • 27. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
    Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
    J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antibacterial activity of sisomicin in comparison with gentamicin].
    Scheer M
    Arzneimittelforschung; 1976; 26(5):772-8. PubMed ID: 9099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibacterial activity of fosfomycin and of the association fosfomycin-rifampicin, upon gram negative bacteria (author's transl)].
    Zemelman R; González C; Mondaca MA
    Rev Med Chil; 1980 Dec; 108(12):1112-7. PubMed ID: 7302408
    [No Abstract]   [Full Text] [Related]  

  • 30. [Activity of various semisynthetic aminoglycoside antibiotics on gentamicin-sensitive and gentamicin-resistant bacterial populations].
    Zemelman R; Bello H; Mondaca MA
    Rev Med Chil; 1983 Mar; 111(3):255-61. PubMed ID: 6648106
    [No Abstract]   [Full Text] [Related]  

  • 31. Synergism between fosfomycin and nalidixic acid in vitro.
    Ullmann U
    J Antimicrob Chemother; 1979 Sep; 5(5):612-3. PubMed ID: 115834
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective effect of fosfomycin on gentamicin-induced lipid peroxidation of rat renal tissue.
    Yanagida C; Ito K; Komiya I; Horie T
    Chem Biol Interact; 2004 Jul; 148(3):139-47. PubMed ID: 15276870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of netilmicin, gentamicin, tobramycin and amikacin against glucose fermenting and nonfermenting bacteria.
    DiPersio JR; Krafczyk TL
    Chemotherapy; 1980; 26(5):323-33. PubMed ID: 7389428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importation of Fosfomycin Resistance fosA3 Gene to Europe.
    Mendes AC; Rodrigues C; Pires J; Amorim J; Ramos MH; Novais Â; Peixe L
    Emerg Infect Dis; 2016 Feb; 22(2):346-8. PubMed ID: 26812028
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro activity of the next-generation aminoglycoside plazomicin alone and in combination with colistin, meropenem, fosfomycin or tigecycline against carbapenemase-producing Enterobacteriaceae strains.
    Rodríguez-Avial I; Pena I; Picazo JJ; Rodríguez-Avial C; Culebras E
    Int J Antimicrob Agents; 2015 Dec; 46(6):616-21. PubMed ID: 26391381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of fosfomycin trometamol against pathogens from urinary tract infections: a Spanish multicenter study.
    García-Rodríguez JA; Trujillano Martín I; Baquero F; Cisterna R; Gobernado M; Liñares F; Martín-Luengo F; Piédrola G
    J Chemother; 1997 Dec; 9(6):394-402. PubMed ID: 9491838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Susceptibility to fosfomycin of hospital strains isolated in Nantes (France). Frequency of mutation to resistance.
    Courtieu AL; Drugeon H; Billaudel S
    Chemotherapy; 1977; 23 Suppl 1():25-36. PubMed ID: 401717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fosfomycin: an oral agent for urinary infection caused by extended spectrum beta-lactamase producing organisms.
    Hutley EJ; Chand MA; Hounsome G; Kelsey MC
    J Infect; 2010 Apr; 60(4):308-9. PubMed ID: 20114062
    [No Abstract]   [Full Text] [Related]  

  • 40. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
    Aris P; Boroumand MA; Rahbar M; Douraghi M
    Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.